All Type of News
Competition stiff for cephalosporin market
Many major pharmaceutical manufacturers are rushing to produce cephalosporin antibiotics with hope of acquiring large share of the domestic cephalosporin market valued at 500 billion won, which is forecast to become m...
KFDA approves Vimpat as adjunct antiepileptic drug
The Korea Food and Drug Administration said on August 6 it has approved UCB's Vimpat (lacosamide) for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain.
Vimpat is an orally-available ...
List of drug procurement unnecessary from October
The Ministry of Health and Welfare Affairs said on August 16 that hospitals and pharmacies will be allowed not to submit a list of monthly drug transactions to the Health Insurance Review Assessment and Service from O...
Number of healthcare institutions up 20,000 for 10 years
The Health Insurance Review Assessment and Service says a total number of healthcare institutions as of June 2010 were 81,142, up 19,336 from 2000.
By profession, recuperation hospitals marked a tremendous growth r...
OTC products to rise up to 50 percent
Some drug manufacturers intend to increase their over-the-counter drugs by more than 50 percent, as part of efforts to boost sluggish sales in the domestic market.
Yuyu Pharm said it will increase the price of Beno...
Green Cross emerges as No. 1 pharmaceutical company in first half
Although Green Cross Corp., which ranked second in terms of revenue last year, its first half revenue jumped 72.9 percent to 447.5 billion won while it earned an operating profit of 109.9 billion won ― 231.8 percent u...
Lee names vice health minister
President Lee Myung-bak nominated Choi Won-hyung, Policy Chief at the Health Ministry of Planning and Coordination, for the ministry's next post, Cheong Wa Dae said on August 13.
Born in South Kyungsang Province i...
Health ministry to delay evaluation plan for 1,880 OTCs
The Ministry of Health and Welfare Affairs said on August 13 that it will evaluate he economic effectiveness of insurance-covered 1,880 over-the-counter drugs until the second half of next year.
Of the 1,880 medici...
Unified distribution system should be viable
The recent decision of the Korea Pharmaceutical Manufacturers Association to support the delay of the controversial unified distribution system will not only be helpful to the budget for national health insurance, but...
Green Cross to produce once-daily influenza treatment
Green Cross Corp., a Korean drug firm, will market its investigational antiviral drug. Approval was given on August 15 by the Korea Food and Drug Administration (KFDA) for the sales of the intravenous antiviral named ...
